1. Home
  2. ATRA vs BODI Comparison

ATRA vs BODI Comparison

Compare ATRA & BODI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATRA
  • BODI
  • Stock Information
  • Founded
  • ATRA 2012
  • BODI 1998
  • Country
  • ATRA United States
  • BODI United States
  • Employees
  • ATRA N/A
  • BODI N/A
  • Industry
  • ATRA Biotechnology: Biological Products (No Diagnostic Substances)
  • BODI Industrial Machinery/Components
  • Sector
  • ATRA Health Care
  • BODI Industrials
  • Exchange
  • ATRA Nasdaq
  • BODI Nasdaq
  • Market Cap
  • ATRA 65.1M
  • BODI 53.3M
  • IPO Year
  • ATRA 2014
  • BODI N/A
  • Fundamental
  • Price
  • ATRA $9.44
  • BODI $7.57
  • Analyst Decision
  • ATRA Buy
  • BODI Strong Buy
  • Analyst Count
  • ATRA 6
  • BODI 3
  • Target Price
  • ATRA $25.70
  • BODI $12.33
  • AVG Volume (30 Days)
  • ATRA 436.6K
  • BODI 18.9K
  • Earning Date
  • ATRA 03-27-2025
  • BODI 03-10-2025
  • Dividend Yield
  • ATRA N/A
  • BODI N/A
  • EPS Growth
  • ATRA N/A
  • BODI N/A
  • EPS
  • ATRA N/A
  • BODI N/A
  • Revenue
  • ATRA $100,439,000.00
  • BODI $451,432,000.00
  • Revenue This Year
  • ATRA $1,339.87
  • BODI N/A
  • Revenue Next Year
  • ATRA N/A
  • BODI N/A
  • P/E Ratio
  • ATRA N/A
  • BODI N/A
  • Revenue Growth
  • ATRA 2111.34
  • BODI N/A
  • 52 Week Low
  • ATRA $5.40
  • BODI $5.14
  • 52 Week High
  • ATRA $28.75
  • BODI $11.33
  • Technical
  • Relative Strength Index (RSI)
  • ATRA 44.94
  • BODI 61.83
  • Support Level
  • ATRA $8.02
  • BODI $7.04
  • Resistance Level
  • ATRA $9.10
  • BODI $7.86
  • Average True Range (ATR)
  • ATRA 1.12
  • BODI 0.64
  • MACD
  • ATRA -0.02
  • BODI 0.09
  • Stochastic Oscillator
  • ATRA 45.13
  • BODI 83.27

About ATRA Atara Biotherapeutics Inc.

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).

About BODI The Beachbody Company Inc. Class A Common Stock

The Beachbody Co Inc is a health and wellness platform providing fitness, nutrition and stress-reducing programs to its customers. The product offerings of the company include Digital Subscriptions, Nutritional Products, and Connected Fitness Products. It earns the majority of its revenue from the United States. The company operates and manages its business in two operating segments, Beachbody and Other.

Share on Social Networks: